Table 1.
Clinicopathological characteristics of the subjects
| Characteristics | HIPEC Group (n = 40) | Control group (n = 40) | P value |
|---|---|---|---|
| Sex (n, %) | |||
| Male | 23 (57.5) | 23 (57.5) | 1 |
| Female | 17 (42.5) | 17 (42.5) | |
| Mean age (years, range) | 59 ± 10 (23–72) | 58 ± 10 (36–74) | 0.95 |
| Mean KPS score (range) | 85 ± 6 (70–90) | 85 ± 6 (70–90) | 0.979 |
| Histopathology (n, %) | |||
| Adenocarcinoma (poor or moderately differentiated) (n, %) | 25 (62.5) | 26 (65) | 1 |
| Adenocarcinoma (Mucinous, signet cell or other type) (n, %) | 15 {37.5) | 14 (35) | |
| Pre-operative Blood physiological and biochemical Parameters | |||
| WBC (109/L) | 5.7 ± 1.4 | 5.7 ± 1.4 | 0.785 |
| RBC (1012/L) | 4.2 ± 0.6 | 4.3 ± 0.5 | 0.78 |
| Hb (g/L) | 130 ± 14 | 127 ± 20 | 0.339 |
| Alb (g/L) | 40 ± 5 | 39 ± 4 | 0.152 |
| AST (IU/L) | 20.4 ± 6.3 | 19.4 ± 8.1 | 0.094 |
| ALT (IU/L) | 20.3 ± 9.3 | 17.1 ± 8.2 | 0.854 |
| TB (umol/L) | 13.2 ± 4.6 | 12.9 ± 3.9 | 0.456 |
| DB (umol/L) | 2.2 ± 1.0 | 2.3 ± 0.08 | 0.626 |
| SCr (umol/L) | 73.5 ± 15.2 | 76.8 ± 27.3 | 0.134 |
| K+ (mmol/L) | 3.95 ± 0.45 | 3.84 ± 0.39 | 0.456 |
| Na+ (mmol/L) | 141 ± 5 | 140 ± 4 | 0.334 |
KPS Karnofsky Performance Score, WBC White Blood Cell Count, RBC Red Blood Cell Count, Hb Hemoglobin, Alb Albumin, AST Aspartate Aminotransferase, ALT Alanine transaminase, TB Total Bilirubin, DB Direct Bilirubin, SCr Serum Creatinine, K+ Potassium Ion, Na+ Sodium Ion, cT3 clinical evidence of sub-serosal invasion, cT4 clinical evidence of serosal invasion